Moraxella catarrhalis
Moraxella catarrhalis is a Gram-negative, aerobic, oxidase-positive diplococcus bacterium that is frequently found in the human respiratory tract. It is a significant human pathogen that causes infections primarily in the upper respiratory tract and the middle ear.
Classification[edit]
Moraxella catarrhalis belongs to the Moraxellaceae family of the Gammaproteobacteria class. It was previously known as Micrococcus catarrhalis and Neisseria catarrhalis before being classified under the Moraxella genus.
Pathogenesis[edit]
Moraxella catarrhalis is a common cause of otitis media in children and respiratory tract infections in adults with chronic obstructive pulmonary disease (COPD). It has also been associated with bacteremia, meningitis, endocarditis, and septic arthritis in rare cases.
Treatment[edit]
The treatment of Moraxella catarrhalis infections typically involves antibiotics. The bacterium is generally susceptible to amoxicillin-clavulanate, cefuroxime, and macrolide antibiotics. However, resistance to penicillin and ampicillin has been reported.
Epidemiology[edit]
Moraxella catarrhalis is a common inhabitant of the human upper respiratory tract. It is found in approximately 3% of adults and up to 15% of children. The bacterium is spread through respiratory droplets.
See also[edit]
References[edit]
-
Moraxella catarrhalis
-
Moraxella catarrhalis on blood agar
-
Hockey puck test for Moraxella catarrhalis
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian